Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-931
Closed -$245K – 255
2023
Q3
$245K Sell
931
-78
-8% -$20.9K 0.02% 214
2023
Q2
$283K Sell
1,009
-169
-14% -$50.3K 0.03% 203
2023
Q1
$328K Buy
1,178
+77
+7% +$21.3K 0.04% 184
2022
Q4
$305K Sell
1,101
-35
-3% -$9.88K 0.04% 183
2022
Q3
$304K Buy
+1,136
New +$241K 0.05% 173
2022
Q1
– Sell
-1,426
Closed -$342K – 223
2021
Q4
$342K Hold
1,426
– – 0.06% 156
2021
Q3
$404K Buy
+1,426
New +$467K 0.09% 105

Other funds holding BIIB

Zhang Financial's BIIB Position: Q4 2023 in Review

Zhang Financial sold out of Biogen (BIIB) in Q4 2023, closing a stake of 931 shares — an estimated $245K sold.

Zhang Financial first reported a position in BIIB in Q3 2021 and held it in 7 quarters. The position peaked at $404K in Q3 2021. 1,003 funds tracked by Wall St. Rank hold BIIB as of Q4 2023.

  • Zhang Financial reported no remaining Biogen position as of Q4 2023 after selling out during the quarter.
  • Zhang Financial sold 931 Biogen shares in Q4 2023, an estimated $245K.
  • Zhang Financial first reported a position in Biogen in Q3 2021 and held it in 7 quarters.
  • Zhang Financial's Biogen position peaked at $404K in Q3 2021.
  • 1,003 funds tracked by Wall St. Rank held Biogen as of Q4 2023.

Based on Zhang Financial's 13F filing for Q4 2023, filed 31 Jan 2024.